Nicole M. Zimmerman

Classroom intervention to change peers' attitudes towards children who stutter: A feasibility study.

H. Kathard, Amy Zoetmulder, F. Walters, 2014, The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings.

Development of a claims-based flare algorithm for systemic lupus erythematosus

J. Birt, D. Nelson, H. Varker, 2022, Current medical research and opinion.

Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical Practice.

D. Irwin, R. Malik, J. Manjelievskaia, 2022, Clinical therapeutics.

Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020

D. Savitz, W. V. La Via, B. Limone, 2022, The Journal of infectious diseases.

Healthcare Costs Among Patients with Psoriasis Treated with Ixekizumab Versus Secukinumab in Real-World Settings Over 24 Months

R. Burge, A. Blauvelt, B. Zhu, 2022, PharmacoEconomics - Open.

SELF-CONCEPT, RESILIENCY, AND IDENTITY FACTORS AMONG GAY AND LESBIAN INDIVIDUALS: A REVIEW AND CRITIQUE OF THE LITERATURE

Nicole M. Zimmerman, 2000 .

Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings

R. Burge, A. Blauvelt, B. Zhu, 2022, Journal of medical economics.

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis

L. Morgan, E. Packnett, P. Ghaswalla, 2023, Human vaccines & immunotherapeutics.

Racial variation in healthcare resource utilization and expenditures in knee/hip osteoarthritis patients: A retrospective analysis of a Medicaid population.

A. Zagar, R. Robinson, E. Packnett, 2023, Journal of Medical Economics.

Real-world analysis of cost, treatment patterns, and outcomes of patients with metastatic cutaneous squamous cell carcinoma in the US

E. Ruiz, G. Konidaris, Nicole M. Zimmerman, 2023, Expert review of pharmacoeconomics & outcomes research.